Project Grant R01DA059378

Award Date 6/1/24
Completion Date 3/31/29
Dollars Obligated $1.4M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New Haven, CT 06519, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to determine the impacts of prenatal exposure to cannabis on childhood adiposity and cardiometabolic health. The $234,000 award, running from August 2024 to July 2026, will allow researchers at the University of Colorado-Denver to measure levels of delta-9-tetrahydrocannabinol (D9-THC) and cannabidiol (CBD) in maternal serum and...
The federal Project Grant award R01DA057317, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), will support research to investigate the effects of cannabinoid exposure on neurodevelopment and behavior. The $800,267 award, spanning from July 1, 2024 to May 31, 2029, will utilize a zebrafish model system to: 1) measure morphological and behavioral alterations in anxiety and locomotion; 2) assess...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $188,482 to study the prevalence and effects of cannabidiol (CBD) use during pregnancy. The 5-year project, awarded on February 1, 2025, will be conducted by the University of Colorado-Denver to: Estimate the prevalence of CBD use by trimester among pregnant women receiving prenatal care at the university's clinics. Characterize the demographics,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,383,618.00 to The Johns Hopkins University to study the effects of adolescent cannabis use on prefrontal cortex maturation and cognitive function. The key objectives are to investigate how microglia, a type of immune cell in the brain, mediate the adverse impacts of tetrahydrocannabinol (THC) from cannabis on the development of the prefrontal...
This $443,263 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a 5-year study to characterize the effects of recreational cannabis use on sleep in women of childbearing age. The study will pair sleep behavior with nocturnal physiological measures of brain activity, stress reactivity, and autonomic nervous system function to delineate the proximal impacts of acute cannabis exposure across different...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $390,635 to the University of Pittsburgh to conduct a multi-phase research project aimed at developing a novel intervention to reduce tobacco and cannabis use among pregnant and postpartum individuals, particularly those from minoritized groups. The project has three key objectives: 1) Conduct formative research on the experiences of marginalized...
This $356,829 Project Grant award from the Maternal and Child Health Bureau (CFDA 93.110 Maternal and Child Health Federal Consolidated Programs) will support a research project at Towson University to examine cannabis communication during prenatal care visits and its impact on maternal and neonatal health outcomes. The key objectives are to: (1) analyze variations in cannabis communication received by pregnant women across states and sociodemographic characteristics; (2) evaluate the...
The federal Project Grant award F31DA060014 for $126,442 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The purpose of this grant is to investigate the effects of delta-9-tetrahydrocannabinol (THC) exposure during the third trimester of pregnancy on the development of the primary visual cortex in ferrets. The research aims to determine how prenatal THC exposure impacts the expression and function of cannabinoid type-1...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
This $189,540 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to characterize the independent and additive effects of schizophrenia and cannabis use on terminal type-specific cannabinoid CB1 receptor (CB1R) expression and signaling in the dorsolateral prefrontal cortex. The research aims to clarify how these CB1R alterations impact working memory function, using a cross-species approach...

EFFECTS OF EARLY-LIFE CANNABINOID EXPOSURE ON PREFRONTAL CIRCUITRY AND COGNITIVE BEHAVIOR ACROSS DEVELOPMENT - PROJECT SUMMARY CANNABIS CONSUMPTION DURING PREGNANCY AND LACTATION HAS REACHED 7-15% IN PREGNANT WOMEN AND NURSING MOTHERS IN RECENT YEARS, AND WILL LIKELY RISE DUE TO WIDESPREAD LEGALIZATION. INCREASED AVAILABILITY OF CANNABIS HAS LED TO THE PUBLIC PERCEPTION THAT IT IS A SAFE NATURAL REMEDY FOR PREGNANCY-RELATED AILMENTS AND POSTPARTUM MOOD DISORDERS. YET, GROWING CLINICAL AND PRECLINICAL DATA SUGGEST PRENATAL AND PERINATAL CANNABIS EXPOSURE IS ASSOCIATED WITH LONG-TERM NEURODEVELOPMENTAL CONSEQUENCES IN CHILDREN, INCLUDING SENSORIMOTOR, EMOTIONAL, AND COGNITIVE DEFICITS, AS WELL AS INCREASED RISK FOR ILLICIT DRUG USE IN ADOLESCENCE AND ADULTHOOD. THE NEURAL MECHANISMS AND SENSITIVE PERIODS UNDERLYING THESE LONG-TERM EFFECTS ARE STILL POORLY UNDERSTOOD, MAKING IT CHALLENGING TO PROVIDE ACCURATE MEDICAL ADVICE FOR RISK ASSESSMENT OF CANNABIS USE IN MOTHERS. TO ADDRESS THIS CHALLENGE, OUR OVERALL GOAL IS TO IDENTIFY THE DEVELOPMENTAL PROCESSES AND CIRCUIT-SPECIFIC MECHANISMS UNDERLYING THE EFFECTS OF EARLY-LIFE CANNABINOID EXPOSURE ON THE EMERGENCE OF COGNITIVE BEHAVIORS. WE WILL FOCUS ON THE MEDIAL PREFRONTAL CORTEX (MPFC) DUE TO ITS HIGH LEVELS OF CANNABINOID RECEPTOR EXPRESSION DURING DEVELOPMENT, AND ITS CRITICAL ROLE IN COGNITIVE PROCESSING. WE WILL ASSESS THE CIRCUIT AND NETWORK EFFECTS OF EARLY- LIFE EXPOSURE TO THE TWO MOST WIDELY USED AND FREQUENTLY COMBINED CANNABINOIDS, 9-TETRAHYDROCANNABINOL (THC) AND CANNABIDIOL (CBD), IN MOUSE PUPS ACROSS DEVELOPMENT. WE WILL TEST THE CENTRAL HYPOTHESIS THAT EARLY-LIFE CANNABINOID EXPOSURE DISRUPTS MPFC MATURATION BY INTERFERING WITH NETWORK SYNCHRONIZATION DURING A CRITICAL DEVELOPMENTAL WINDOW, RESULTING IN ABNORMAL NEURONAL ACTIVATION DURING COGNITIVE BEHAVIORS IN ADOLESCENCE AND ADULTHOOD. WE WILL LEVERAGE OUR NOVEL LONGITUDINAL 2-PHOTON IMAGING TECHNIQUE IN DEVELOPING MICE TO ASSESS THE IMPACT OF THC, CBD, AND THC+CBD EXPOSURE THROUGH THREE AIMS. IN AIM 1, WE WILL REVEAL THE SPATIAL AND TEMPORAL PATTERNS OF IN VIVO NETWORK ACTIVITY AND ECB DYNAMICS ACROSS DEVELOPMENT AND DETERMINE CRITICAL WINDOWS DURING WHICH ALTERED ECB SIGNALING AFFECTS THESE NETWORK DYNAMICS. IN AIM 2, WE WILL ASSESS HOW EARLY-LIFE THC, CBD, OR THC+CBD EXPOSURE IMPACTS ECB AND CALCIUM DYNAMICS DURING DEVELOPMENT USING LONGITUDINAL 2-PHOTON IMAGING. WE WILL ALSO EXAMINE THE EFFECTS OF CANNABINOID EXPOSURE ON SYNAPTIC CONNECTIVITY AND THE BALANCE BETWEEN EXCITATION AND INHIBITION IN THE MPFC. IN AIM 3, WE WILL ASSESS THE IMPACT OF EARLY-LIFE CANNABINOID EXPOSURE ON THE NEURAL CORRELATES OF COGNITIVE BEHAVIORS IN THE MPFC ACROSS ADOLESCENCE AND ADULTHOOD. WE WILL ALSO SYSTEMATICALLY ASSESS THE BEHAVIORAL OUTCOMES AFTER EARLY-LIFE CANNABINOID EXPOSURE LONGITUDINALLY ACROSS NEONATAL, ADOLESCENCE AND EARLY ADULTHOOD. TOGETHER, OUTCOMES OF THIS PROJECT WILL IDENTIFY NEURAL MECHANISMS UNDERLYING LATER-LIFE BEHAVIORAL DEFICITS AS A RESULT OF EARLY-LIFE CANNABINOID EXPOSURE. AS SUCH, THIS PROJECT IS EXPECTED TO HAVE A SIGNIFICANT TRANSLATIONAL IMPACT ON CLINICAL EFFORTS TO PROVIDE GUIDELINES ON CANNABIS USE IN MOTHERS AND TIMELY INTERVENTIONS FOR AFFECTED CHILDREN.

Posted 5/24/24, 12:00 AM